PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 6, 2026Frontiers in Digital Health2 citationsOpen Access

Quality assessment of large language model–generated prior authorization letters in nephrology

NANoppawit AiumtrakulCTCharat ThongprayoonCKChutawat Kookanok

Key Points

  • The study aims to evaluate the quality of prior authorization letters generated by ChatGPT-5 for nephrology medications.
  • Created a standardized prompt for 29 nephrology scenarios.
  • Reviewed generated letters against criteria for correctness and reasoning.
  • Used FDA drug labels, KDIGO guidelines, and clinical trials as references.
  • 3.5% of letters contained false statements.
  • 79.3% had correct ICD-10 coding with most errors in CKD staging.
  • 93.1% of letters cited valid references, though some links were inaccessible.
  • 89.7% demonstrated strong clinical reasoning supported by guidelines.

Abstract

Background Prior authorization (PA) is a major source of administrative burden, treatment delay, and clinician burnout. Artificial intelligence (AI), particularly large language models (LLMs), is increasingly used to assist with clinical documentation, yet its reliability for payer-facing administrative tasks remains uncertain. Objective To evaluate the quality of PA letters drafted by ChatGPT-5 for commonly used medications requiring PA in nephrology. Quality was evaluated based on correctness and strength of clinical reasoning. Methods We created a single standardized prompt and applied it across 29 nephrology scenarios to generate PA letters. Each PA letter was reviewed against four criteria: 1) absence of false statements or hallucinations, 2) correctness of ICD-10 coding, 3) presence and validity of citations, and 4) clinical reasoning, rated on a 4-point Likert scale (illogical, weak, adequate and strong). FDA drug labels, KDIGO guidelines and related randomized controlled trials were used as reference standards. Results Out of 29 letters, one letter (3.5%) contained false statements mentioning an irrelevant clinical trial. The ICD-10 diagnosis code was correct in 23 letters (79.3%), most errors were related to chronic kidney disease (CKD) staging or internal diagnostic inconsistencies. 27 letters (93.1%) cited valid references, with one letter citing an incorrect trial and another one citing a correct KDIGO guideline with inaccessible link. Twenty-six letters (89.7%) demonstrated strong clinical reasoning, supported by guideline-oriented or FDA label–aligned justification. The remaining 3 letters were rated as adequate reasoning. The main areas for improvement involved citing relevant references and emphasizing special considerations, for example Risk Evaluation and Mitigation Strategy (REMS) compliance for eculizumab. Conclusions ChatGPT-5 can generate clinically coherent PA drafts for nephrology medications, but limitations in coding precision and citation reliability persist. With appropriate oversight, AI-assisted documentation may reduce administrative burden while maintaining safety and accuracy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Aiumtrakul et al. (2026) studied this question.

synapsesocial.com/papers/69aa7008531e4c4a9ff59602https://doi.org/10.3389/fdgth.2026.1767648
Ask AI
Helpful
Bookmark
Share
View Full Paper